von Schmiedeberg S, Fritsche E, Ronnau AC, Specker C, Golka K, Richter-HintzD, Schuppe HC, Lehmann P, Ruzicka T, Esser C, Abel J & Gleichmann E. (1999)Polymorphisms of the xenobiotic-metabolizing enzymes CYP1A1 and NAT-2 insystemic sclerosis and lupus erythematosus. Adv Exp Med Biol 455: 147-152.

van der Woude D, Houwing-Duistermaat JJ, Toes RE, Huizinga TW, Thomson W,Worthington J, van der Helm-van Mil AH & de Vries RR. (2009) Quantitativeheritability of anti-citrullinated protein antibody-positive and anti-citrullinatedprotein antibody-negative rheumatoid arthritis. Arthritis Rheum 60(4): 916-923.

van der Vliet A, O'Neill CA, Cross CE, Koostra JM, Volz WG, Halliwell B &Louie S. (1999) Determination of low-molecular-mass antioxidant concentrationsin human respiratory tract lining fluids. Am J Physiol 276(2 Pt 1): L289-96.

van den Wijngaard R, Wankowicz-Kalinska A, Le Poole C, Tigges B, WesterhofW & Das P. (2000) Local immune response in skin of generalized vitiligo patients.Destruction of melanocytes is associated with the prominent presence of CLA+ Tcells at the perilesional site. Lab Invest 80(8): 1299-1309.

de Vries RR, van der Woude D, Houwing JJ & Toes RE. (2011) Genetics of ACPApositiverheumatoid arthritis: the beginning of the end? Ann Rheum Dis 70 Suppl 1:i51-4.

de Bruin WC, Wagenmans MJ & Peters WH. (2000) Expression of glutathione Stransferasealpha, P1-1 and T1-1 in the human gastrointestinal tract. Jpn J CancerRes 91(3): 310-316.

Zhong S, Spurr NK, Hayes JD & Wolf CR. (1993) Deduced amino acid sequence,gene structure and chromosomal location of a novel human class Mu glutathione Stransferase,GSTM4. Biochem J 291 ( Pt 1)(Pt 1): 41-50.

Zhao Y, Marotta M, Eichler EE, Eng C & Tanaka H. (2009) Linkage disequilibriumbetween two high-frequency deletion polymorphisms: implications for associationstudies involving the glutathione-S transferase (GST) genes. PLoS Genet 5(5):e1000472.

Zhang ZJ, Hao K, Shi R, Zhao G, Jiang GX, Song Y, Xu X & Ma J. (2011)Glutathione S-transferase M1 (GSTM1) and glutathione S-transferase T1 (GSTT1)null polymorphisms, smoking, and their interaction in oral cancer: a HuGE reviewand meta-analysis. Am J Epidemiol 173(8): 847-857.

Zhang J, Deng J, Zhang C, Lu Y, Liu L, Wu Q, Shao Y, Zhang J, Yang H, Yu B &Wan J. (2010) Association of GSTT1, GSTM1 and CYP1A1 polymorphisms withsusceptibility to systemic lupus erythematosus in the Chinese population. ClinChim Acta 411(11-12): 878-881.

Yun BR, El-Sohemy A, Cornelis MC & Bae SC. (2005) Glutathione S-transferaseM1, T1, and P1 genotypes and rheumatoid arthritis. J Rheumatol 32(6): 992-997.

Yin Z, Ivanov VN, Habelhah H, Tew K & Ronai Z. (2000) Glutathione Stransferasep elicits protection against H2O2-induced cell death via coordinatedregulation of stress kinases. Cancer Res 60(15): 4053-4057.

Yen JH, Chen CJ, Tsai WC, Lin CH, Ou TT, Hu CJ & Liu HW. (2003)Cytochrome P450 and manganese superoxide dismutase genes polymorphisms insystemic lupus erythematosus. Immunol Lett 90(1): 19-24.

Ye Z & Song H. (2005) Glutathione s-transferase polymorphisms (GSTM1, GSTP1and GSTT1) and the risk of acute leukaemia: a systematic review and metaanalysis.Eur J Cancer 41(7): 980-989.

Xue H, Su J, Sun K, Xie W & Wang H. (2012) Glutathione S-transferase M1 andT1 gene polymorphism and COPD risk in smokers: an updated analysis. Mol BiolRep 39(4): 5033-5042.

Xu S, Wang Y, Roe B & Pearson WR. (1998) Characterization of the human classMu glutathione S-transferase gene cluster and the GSTM1 deletion. J Biol Chem273(6): 3517-3527.

Widersten M, Pearson WR, Engstrom A & Mannervik B. (1991) Heterologousexpression of the allelic variant mu-class glutathione transferases mu and psi.Biochem J 276 ( Pt 2)(Pt 2): 519-524.

Wichmann I, Aguilera I, Sousa JM, Bernardos A, Garcia Nunez EJ, Vigil E,Magarino R, Magarino I, Torres A & Nunez-Roldan A. (2006) Antibodies againstglutathione S-transferase T1 in non-solid organ transplanted patients. Transfusion46(9): 1505-1509.

Vrijman C, Kroon MW, Limpens J, Leeflang MM, Luiten RM, van der Veen JP,Wolkerstorfer A & Spuls PI. (2012) The prevalence of thyroid disease in patientswith vitiligo: a systematic review. Br J Dermatol 167(6): 1224-1235.

Vorachek WR, Pearson WR & Rule GS. (1991) Cloning, expression, andcharacterization of a class-mu glutathione transferase from human muscle, theproduct of the GST4 locus. Proc Natl Acad Sci U S A 88(10): 4443-4447.

Uhm YK, Yoon SH, Kang IJ, Chung JH, Yim SV & Lee MH. (2007) Associationof glutathione S-transferase gene polymorphisms (GSTM1 and GSTT1) of vitiligoin Korean population. Life Sci 81(3): 223-227.

Turi S, Nemeth I, Torkos A, Saghy L, Varga I, Matkovics B & Nagy J. (1997)Oxidative stress and antioxidant defense mechanism in glomerular diseases. FreeRadic Biol Med 22(1-2): 161-168.

Tsokos GC. (2011) Systemic lupus erythematosus. N Engl J Med 365(22): 2110-2121.

Tsao BP. (2004) Update on human systemic lupus erythematosus genetics. CurrOpin Rheumatol 16(5): 513-521.

Tsai KJ, Hung IJ, Chow CK, Stern A, Chao SS & Chiu DT. (1998) Impairedproduction of nitric oxide, superoxide, and hydrogen peroxide in glucose 6-phosphate-dehydrogenase-deficient granulocytes. FEBS Lett 436(3): 411-414.

Triester SL, Leighton JA, Leontiadis GI, Gurudu SR, Fleischer DE, Hara AK,Heigh RI, Shiff AD & Sharma VK. (2006) A meta-analysis of the yield of capsuleendoscopy compared to other diagnostic modalities in patients with non-stricturingsmall bowel Crohn's disease. Am J Gastroenterol 101(5): 954-964.

Townsend DM, Tew KD & Tapiero H. (2003) The importance of glutathione inhuman disease. Biomed Pharmacother 57(3-4): 145-155.

Torii M, Wang L, Ma N, Saito K, Hori T, Sato-Ueshima M, Koyama Y, NishikawaH, Katayama N, Mizoguchi A, Shiku H, Yodoi J, Kuribayashi K & Kato T. (2010)Thioredoxin suppresses airway inflammation independently of systemic Th1/Th2immune modulation. Eur J Immunol 40(3): 787-796.

Tingstrom PR, Ekelund U, Kamwendo K & Bergdahl B. (2006) Effects of aproblem-based learning rehabilitation program on physical activity in patients withcoronary artery disease. J Cardiopulm Rehabil 26(1): 32-38.

Tew MB, Ahn CW, Friedman AW, Reveille JD, Tan FK, Alarcon GS, Bastian HM,Fessler BJ, McGwin G,Jr & Lisse JR. (2001) Systemic lupus erythematosus inthree ethnic groups. VIII. Lack of association of glutathione S-transferase nullalleles with disease manifestations. Arthritis Rheum 44(4): 981-983.

Tetlow N, Robinson A, Mantle T & Board P. (2004) Polymorphism of human muclass glutathione transferases. Pharmacogenetics 14(6): 359-368.

Tan KL, Webb GC, Baker RT & Board PG. (1995) Molecular cloning of a cDNAand chromosomal localization of a human theta-class glutathione S-transferasegene (GSTT2) to chromosome 22. Genomics 25(2): 381-387.

Tamer L, Calikoglu M, Ates NA, Yildirim H, Ercan B, Saritas E, Unlu A & Atik U.(2004) Glutathione-S-transferase gene polymorphisms (GSTT1, GSTM1, GSTP1)as increased risk factors for asthma. Respirology 9(4): 493-498.

Takahashi Y, Campbell EA, Hirata Y, Takayama T & Listowsky I. (1993) A basisfor differentiating among the multiple human Mu-glutathione S-transferases andmolecular cloning of brain GSTM5. J Biol Chem 268(12): 8893-8898.

Swope VB, Abdel-Malek Z, Kassem LM & Nordlund JJ. (1991) Interleukins 1alpha and 6 and tumor necrosis factor-alpha are paracrine inhibitors of humanmelanocyte proliferation and melanogenesis. J Invest Dermatol 96(2): 180-185.

Suzuki T, Coggan M, Shaw DC & Board PG. (1987) Electrophoretic andimmunological analysis of human glutathione S-transferase isozymes. Ann HumGenet 51(Pt 2): 95-106.

Sundaresan M, Yu ZX, Ferrans VJ, Irani K & Finkel T. (1995) Requirement forgeneration of H2O2 for platelet-derived growth factor signal transduction. Science270(5234): 296-299.

Su C, Lichtenstein GR, Krok K, Brensinger CM & Lewis JD. (2004) A metaanalysisof the placebo rates of remission and response in clinical trials of activeCrohn's disease. Gastroenterology 126(5): 1257-1269.

Strange RC, Spiteri MA, Ramachandran S & Fryer AA. (2001) Glutathione-Stransferasefamily of enzymes. Mutat Res 482(1-2): 21-26.

Strange RC, Jones PW & Fryer AA. (2000) Glutathione S-transferase: genetics androle in toxicology. Toxicol Lett 112-113: 357-363.

Strange RC & Fryer AA. (1999) The glutathione S-transferases: influence ofpolymorphism on cancer susceptibility. IARC Sci Publ (148)(148): 231-249.

Stich HF & Anders F. (1989) The involvement of reactive oxygen species in oralcancers of betel quid/tobacco chewers. Mutat Res 214(1): 47-61.

Stevens JF & Maier CS. (2008) Acrolein: sources, metabolism, and biomolecularinteractions relevant to human health and disease. Mol Nutr Food Res 52(1): 7-25.

Stahl EA, Raychaudhuri S, Remmers EF, Xie G, Eyre S, Thomson BP, Li Y,Kurreeman FA, Zhernakova A, Hinks A, Guiducci C, Chen R, Alfredsson L, AmosCI, Ardlie KG, BIRAC Consortium, Barton A, Bowes J, Brouwer E, Burtt NP,Catanese JJ, Coblyn J, Coenen MJ, Costenbader KH, Criswell LA, Crusius JB, CuiJ, de Bakker PI, De Jager PL, Ding B, Emery P, Flynn E, Harrison P, Hocking LJ,Huizinga TW, Kastner DL, Ke X, Lee AT, Liu X, Martin P, Morgan AW,Padyukov L, Posthumus MD, Radstake TR, Reid DM, Seielstad M, Seldin MF,Shadick NA, Steer S, Tak PP, Thomson W, van der Helm-van Mil AH, van derHorst-Bruinsma IE, van der Schoot CE, van Riel PL, Weinblatt ME, Wilson AG,Wolbink GJ, Wordsworth BP, YEAR Consortium, Wijmenga C, Karlson EW, ToesRE, de Vries N, Begovich AB, Worthington J, Siminovitch KA, Gregersen PK,Klareskog L & Plenge RM. (2010) Genome-wide association study meta-analysisidentifies seven new rheumatoid arthritis risk loci. Nat Genet 42(6): 508-514.

Sprenger R, Schlagenhaufer R, Kerb R, Bruhn C, Brockmoller J, Roots I &Brinkmann U. (2000) Characterization of the glutathione S-transferase GSTT1deletion: discrimination of all genotypes by polymerase chain reaction indicates atrimodular genotype-phenotype correlation. Pharmacogenetics 10(6): 557-565.

Song GG, Bae SC & Lee YH. (2012) The glutathione S-transferase M1 and P1polymorphisms and rheumatoid arthritis: a meta-analysis. Mol Biol Rep 39(12):10739-10745.

Smith ML & Glass GV. (1977) Meta-analysis of psychotherapy outcome studies.Am Psychol 32(9): 752-760.

Smith G, Stanley LA, Sim E, Strange RC & Wolf CR. (1995) Metabolicpolymorphisms and cancer susceptibility. Cancer Surv 25: 27-65.

Smith CM, Kelsey KT, Wiencke JK, Leyden K, Levin S & Christiani DC. (1994)Inherited glutathione-S-transferase deficiency is a risk factor for pulmonaryasbestosis. Cancer Epidemiol Biomarkers Prev 3(6): 471-477.

Shi J, Wu C, Lin Y, Chen YX, Zhu L & Xie WF. (2006) Long-term effects of middoseursodeoxycholic acid in primary biliary cirrhosis: a meta-analysis ofrandomized controlled trials. Am J Gastroenterol 101(7): 1529-1538.

Sheth VM, Guo Y & Qureshi AA. (2013) Comorbidities associated with vitiligo: aten-year retrospective study. Dermatology 227(4): 311-315.

Sheehan D, Meade G, Foley VM & Dowd CA. (2001) Structure, function andevolution of glutathione transferases: implications for classification of nonmammalianmembers of an ancient enzyme superfamily. Biochem J 360(Pt 1): 1-16.

Shah D, Sah S & Nath SK. (2013) Interaction between glutathione and apoptosis insystemic lupus erythematosus. Autoimmun Rev 12(7): 741-751.

Shah D, Kiran R, Wanchu A & Bhatnagar A. (2010) Oxidative stress in systemiclupus erythematosus: relationship to Th1 cytokine and disease activity. ImmunolLett 129(1): 7-12.

Sekine K, Mochizuki H, Inoue Y, Kobayashi T, Suganuma E, Matsuda S &Arakawa H. (2012) Regulation of oxidative stress in patients with Kawasakidisease. Inflammation 35(3): 952-958.

Seidegard J, Vorachek WR, Pero RW & Pearson WR. (1988) Hereditary differencesin the expression of the human glutathione transferase active on trans-stilbeneoxide are due to a gene deletion. Proc Natl Acad Sci U S A 85(19): 7293-7297.

Seidegard J, Pero RW, Miller DG & Beattie EJ. (1986) A glutathione transferase inhuman leukocytes as a marker for the susceptibility to lung cancer. Carcinogenesis7(5): 751-753.

Scott DL, Wolfe F & Huizinga TW. (2010) Rheumatoid arthritis. Lancet376(9746): 1094-1108.

Scott DL & Steer S. (2007) The course of established rheumatoid arthritis. BestPract Res Clin Rheumatol 21(5): 943-967.

Saitoh M, Nishitoh H, Fujii M, Takeda K, Tobiume K, Sawada Y, Kawabata M,Miyazono K & Ichijo H. (1998) Mammalian thioredoxin is a direct inhibitor ofapoptosis signal-regulating kinase (ASK) 1. EMBO J 17(9): 2596-2606.

Russo MW. (2007) How to Review a Meta-analysis. Gastroenterol Hepatol (N Y)3(8): 637-642.

Rupasree Y, Naushad SM, Rajasekhar L & Kutala VK. (2013) Association ofgenetic variants of xenobiotic metabolic pathway with systemic lupuserythematosus. Indian J Biochem Biophys 50(5): 447-452.

Rossini A, Rapozo DC, Soares Lima SC, Guimaraes DP, Ferreira MA, Teixeira R,Kruel CD, Barros SG, Andreollo NA, Acatauassu R, Matos HJ, Albano RM &Pinto LF. (2007) Polymorphisms of GSTP1 and GSTT1, but not of CYP2A6,CYP2E1 or GSTM1, modify the risk for esophageal cancer in a western population.Carcinogenesis 28(12): 2537-2542.

Ross VL, Board PG & Webb GC. (1993) Chromosomal mapping of the human Muclass glutathione S-transferases to 1p13. Genomics 18(1): 87-91.

Ross VL & Board PG. (1993) Molecular cloning and heterologous expression of analternatively spliced human Mu class glutathione S-transferase transcript. BiochemJ 294 ( Pt 2)(Pt 2): 373-380.

Ross AD, Banda NK, Muggli M & Arend WP. (2004) Enhancement of collageninducedarthritis in mice genetically deficient in extracellular superoxide dismutase.Arthritis Rheum 50(11): 3702-3711.

Rebbeck TR. (1997) Molecular epidemiology of the human glutathione Stransferasegenotypes GSTM1 and GSTT1 in cancer susceptibility. CancerEpidemiol Biomarkers Prev 6(9): 733-743.

Ratsep R, Kingo K, Karelson M, Reimann E, Raud K, Silm H, Vasar E & Koks S.(2008) Gene expression study of IL10 family genes in vitiligo skin biopsies,peripheral blood mononuclear cells and sera. Br J Dermatol 159(6): 1275-1281.

Raimondi S, Paracchini V, Autrup H, Barros-Dios JM, Benhamou S, Boffetta P,Cote ML, Dialyna IA, Dolzan V, Filiberti R, Garte S, Hirvonen A, Husgafvel-Pursiainen K, Imyanitov EN, Kalina I, Kang D, Kiyohara C, Kohno T, Kremers P,Lan Q, London S, Povey AC, Rannug A, Reszka E, Risch A, Romkes M,Schneider J, Seow A, Shields PG, Sobti RC, Sorensen M, Spinola M, Spitz MR,Strange RC, Stucker I, Sugimura H, To-Figueras J, Tokudome S, Yang P, Yuan JM,Warholm M & Taioli E. (2006) Meta- and pooled analysis of GSTT1 and lungcancer: a HuGE-GSEC review. Am J Epidemiol 164(11): 1027-1042.

Rahman A & Isenberg DA. (2008) Systemic lupus erythematosus. N Engl J Med358(9): 929-939.

Quartero AO, Meineche-Schmidt V, Muris J, Rubin G & de Wit N. (2005) Bulkingagents, antispasmodic and antidepressant medication for the treatment of irritablebowel syndrome. Cochrane Database Syst Rev (2)(2): CD003460.

Prahalad S, Hansen S, Whiting A, Guthery SL, Clifford B, McNally B, Zeft AS,Bohnsack JF & Jorde LB. (2009) Variants in TNFAIP3, STAT4, and C12orf30 lociassociated with multiple autoimmune diseases are also associated with juvenileidiopathic arthritis. Arthritis Rheum 60(7): 2124-2130.

Pons-Estel GJ, Alarcon GS, Scofield L, Reinlib L & Cooper GS. (2010)Understanding the epidemiology and progression of systemic lupus erythematosus.Semin Arthritis Rheum 39(4): 257-268.

Perl A, Gergely P,Jr & Banki K. (2004) Mitochondrial dysfunction in T cells ofpatients with systemic lupus erythematosus. Int Rev Immunol 23(3-4): 293-313.

Pemble S, Schroeder KR, Spencer SR, Meyer DJ, Hallier E, Bolt HM, Ketterer B &Taylor JB. (1994) Human glutathione S-transferase theta (GSTT1): cDNA cloningand the characterization of a genetic polymorphism. Biochem J 300 ( Pt 1)(Pt 1):271-276.

Pedersen M, Jacobsen S, Garred P, Madsen HO, Klarlund M, Svejgaard A,Pedersen BV, Wohlfahrt J & Frisch M. (2007) Strong combined gene-environmenteffects in anti-cyclic citrullinated peptide-positive rheumatoid arthritis: anationwide case-control study in Denmark. Arthritis Rheum 56(5): 1446-1453.

Pearson WR, Vorachek WR, Xu SJ, Berger R, Hart I, Vannais D & Patterson D.(1993) Identification of class-mu glutathione transferase genes GSTM1-GSTM5 onhuman chromosome 1p13. Am J Hum Genet 53(1): 220-233.

Pattison DJ & Winyard PG. (2008) Dietary antioxidants in inflammatory arthritis:do they have any role in etiology or therapy? Nat Clin Pract Rheumatol 4(11): 590-596.

Parl FF. (2005) Glutathione S-transferase genotypes and cancer risk. Cancer Lett221(2): 123-129.

Pal A, Hu X, Zimniak P & Singh SV. (2000) Catalytic efficiencies of allelic variantsof human glutathione S-transferase Pi in the glutathione conjugation of alpha, betaunsaturatedaldehydes. Cancer Lett 154(1): 39-43.

Padyukov L, Silva C, Stolt P, Alfredsson L & Klareskog L. (2004) A geneenvironmentinteraction between smoking and shared epitope genes in HLA-DRprovides a high risk of seropositive rheumatoid arthritis. Arthritis Rheum 50(10):3085-3092.

Ozturk HS, Cimen MY, Cimen OB, Kacmaz M & Durak I. (1999)Oxidant/antioxidant status of plasma samples from patients with rheumatoidarthritis. Rheumatol Int 19(1-2): 35-37.

Ozdemir H, Ciftci E, Tapisiz A, Ince E, Tutar E, Atalay S & Dogru U. (2010)Clinical and epidemiological characteristics of children with Kawasaki disease inTurkey. J Trop Pediatr 56(4): 260-262.

Orozco G, Eyre S, Hinks A, Ke X, Wellcome Trust Case Control consortiumYEAR Consortium, Wilson AG, Bax DE, Morgan AW, Emery P, Steer S, HockingL, Reid DM, Wordsworth P, Harrison P, Thomson W, Barton A & Worthington J.(2010) Association of CD40 with rheumatoid arthritis confirmed in a large UKcase-control study. Ann Rheum Dis 69(5): 813-816.

Ongenae K, Van Geel N & Naeyaert JM. (2003) Evidence for an autoimmunepathogenesis of vitiligo. Pigment Cell Res 16(2): 90-100.

Ollier W, Davies E, Snowden N, Alldersea J, Fryer A, Jones P & Strange R. (1996)Association of homozygosity for glutathione-S-transferase GSTM1 null alleleswith the Ro+/La- autoantibody profile in patients with systemic lupuserythematosus. Arthritis Rheum 39(10): 1763-1764.

Okada Y, Shinohara M, Kobayashi T, Inoue Y, Tomomasa T, Kobayashi T,Morikawa A & Gunma Kawasaki Disease Study Group. (2003) Effect ofcorticosteroids in addition to intravenous gamma globulin therapy on serumcytokine levels in the acute phase of Kawasaki disease in children. J Pediatr 143(3):363-367.

Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC,Shulman ST, Bolger AF, Ferrieri P, Baltimore RS, Wilson WR, Baddour LM,Levison ME, Pallasch TJ, Falace DA, Taubert KA, Committee on Rheumatic Fever,Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in theYoung, American Heart Association & American Academy of Pediatrics. (2004)Diagnosis, treatment, and long-term management of Kawasaki disease: a statementfor health professionals from the Committee on Rheumatic Fever, Endocarditis andKawasaki Disease, Council on Cardiovascular Disease in the Young, AmericanHeart Association. Circulation 110(17): 2747-2771.

Nelson HH, Wiencke JK, Christiani DC, Cheng TJ, Zuo ZF, Schwartz BS, Lee BK,Spitz MR, Wang M & Xu X. (1995) Ethnic differences in the prevalence of thehomozygous deleted genotype of glutathione S-transferase theta. Carcinogenesis16(5): 1243-1245.

Nebert DW & Vasiliou V. (2004) Analysis of the glutathione S-transferase (GST)gene family. Hum Genomics 1(6): 460-464.

Nebert DW & Dalton TP. (2006) The role of cytochrome P450 enzymes inendogenous signalling pathways and environmental carcinogenesis. Nat RevCancer 6(12): 947-960.

Moyer AM, Salavaggione OE, Hebbring SJ, Moon I, Hildebrandt MA, Eckloff BW,Schaid DJ, Wieben ED & Weinshilboum RM. (2007) Glutathione S-transferase T1and M1: gene sequence variation and functional genomics. Clin Cancer Res 13(23):7207-7216.

Moskal A, Norat T, Ferrari P & Riboli E. (2007) Alcohol intake and colorectalcancer risk: a dose-response meta-analysis of published cohort studies. Int J Cancer120(3): 664-671.

Mosialou E, Ekstrom G, Adang AE & Morgenstern R. (1993) Evidence that ratliver microsomal glutathione transferase is responsible for glutathione-dependentprotection against lipid peroxidation. Biochem Pharmacol 45(8): 1645-1651.

Morinobu S, Morinobu A, Kanagawa S, Hayashi N, Nishimura K & Kumagai S.(2006) Glutathione S-transferase gene polymorphisms in Japanese patients withrheumatoid arthritis. Clin Exp Rheumatol 24(3): 268-273.

Moretti S, Spallanzani A, Amato L, Hautmann G, Gallerani I, Fabiani M & FabbriP. (2002) New insights into the pathogenesis of vitiligo: imbalance of epidermalcytokines at sites of lesions. Pigment Cell Res 15(2): 87-92.

Morens DM, Anderson LJ & Hurwitz ES. (1980) National surveillance ofKawasaki disease. Pediatrics 65(1): 21-25.

Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D & Stroup DF. (1999)Improving the quality of reports of meta-analyses of randomised controlled trials:the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet354(9193): 1896-1900.

Mohammad HASHEMI, Ebrahim ESKANDARI-NASAB, Zahra ZAKERI, MahdiATABAKI, Hamzeh REZAEI, Gholamreza BAHARI, Mohsen TAHERI. (2012) APossible Relationship Between Polymorphisms of Glutathione S-Transferase Ml, PIand Tl Genes and Rheumatoid Arthritis in Zahedah, Southeast Iran Turk JRheumatol 27(4):253-257.

Mo Z, Gao Y, Cao Y, Gao F & Jian L. (2009) An updating meta-analysis of theGSTM1, GSTT1, and GSTP1 polymorphisms and prostate cancer: a HuGE review.Prostate 69(6): 662-688.

Mittal RD, Manchanda PK, Bid HK & Ghoshal UC. (2007) Analysis ofpolymorphisms of tumor necrosis factor-alpha and polymorphic xenobioticmetabolizing enzymes in inflammatory bowel disease: study from northern India. JGastroenterol Hepatol 22(6): 920-924.

Mitchell AE, Morin D, Lame MW & Jones AD. (1995) Purification, massspectrometric characterization, and covalent modification of murine glutathione Stransferases.Chem Res Toxicol 8(8): 1054-1062.

Minelli C, Wei I, Sagoo G, Jarvis D, Shaheen S & Burney P. (2011) Interactiveeffects of antioxidant genes and air pollution on respiratory function and airwaydisease: a HuGE review. Am J Epidemiol 173(6): 603-620.

Minelli C, Granell R, Newson R, Rose-Zerilli MJ, Torrent M, Ring SM, HollowayJW, Shaheen SO & Henderson JA. (2010) Glutathione-S-transferase genes andasthma phenotypes: a Human Genome Epidemiology (HuGE) systematic reviewand meta-analysis including unpublished data. Int J Epidemiol 39(2): 539-562.

Mikuls TR, Levan T, Gould KA, Yu F, Thiele GM, Bynote KK, Conn D, Jonas BL,Callahan LF, Smith E, Brasington R, Moreland LW, Reynolds R, Gaffo A &Bridges SL,Jr. (2012) Impact of interactions of cigarette smoking with NAT2polymorphisms on rheumatoid arthritis risk in African Americans. Arthritis Rheum64(3): 655-664.

Meyer DJ, Coles B, Pemble SE, Gilmore KS, Fraser GM & Ketterer B. (1991)Theta, a new class of glutathione transferases purified from rat and man. Biochem J274 ( Pt 2)(Pt 2): 409-414.

Menghini R. (1988) Genotoxicity of active oxygen species in mammalian cells.Mutat Res 195(3): 215-230.

Melov S, Schneider JA, Day BJ, Hinerfeld D, Coskun P, Mirra SS, Crapo JD &Wallace DC. (1998) A novel neurological phenotype in mice lacking mitochondrialmanganese superoxide dismutase. Nat Genet 18(2): 159-163.

Meister A. (1988) Glutathione metabolism and its selective modification. J BiolChem 263(33): 17205-17208.

McLellan RA, Oscarson M, Alexandrie AK, Seidegard J, Evans DA, Rannug A &Ingelman-Sundberg M. (1997) Characterization of a human glutathione Stransferasemu cluster containing a duplicated GSTM1 gene that causes ultrarapidenzyme activity. Mol Pharmacol 52(6): 958-965.

McInnes IB & Schett G. (2011) The pathogenesis of rheumatoid arthritis. N Engl JMed 365(23): 2205-2219.

McCord JM. (1974) Free radicals and inflammation: protection of synovial fluidby superoxide dismutase. Science 185(4150): 529-531.

Mattey DL, Hutchinson D, Dawes PT, Nixon NB, Clarke S, Fisher J, Brownfield A,Alldersea J, Fryer AA & Strange RC. (2002) Smoking and disease severity inrheumatoid arthritis: association with polymorphism at the glutathione StransferaseM1 locus. Arthritis Rheum 46(3): 640-646.

Mattey DL, Hassell AB, Plant M, Dawes PT, Ollier WR, Jones PW, Fryer AA,Alldersea JE & Strange RC. (1999) Association of polymorphism in glutathione Stransferaseloci with susceptibility and outcome in rheumatoid arthritis: comparisonwith the shared epitope. Ann Rheum Dis 58(3): 164-168.

Mattey DL, Hassell AB, Dawes PT, Jones PW, Yengi L, Alldersea J, Strange RC& Fryer AA. (2000) Influence of polymorphism in the manganese superoxidedismutase locus on disease outcome in rheumatoid arthritis: evidence forinteraction with glutathione S-transferase genes. Arthritis Rheum 43(4): 859-864.

Matsubara T, Furukawa S & Yabuta K. (1990) Serum levels of tumor necrosisfactor, interleukin 2 receptor, and interferon-gamma in Kawasaki disease involvedcoronary-artery lesions. Clin Immunol Immunopathol 56(1): 29-36.

Matejcic M, Li D, Prescott NJ, Lewis CM, Mathew CG & Parker MI. (2011)Association of a deletion of GSTT2B with an altered risk of oesophageal squamouscell carcinoma in a South African population: a case-control study. PLoS One6(12): e29366.

Marx JL. (1987) Oxygen free radicals linked to many diseases. Science 235(4788):529-531.

Maresca V, Roccella M, Roccella F, Camera E, Del Porto G, Passi S, GrammaticoP & Picardo M. (1997) Increased sensitivity to peroxidative agents as a possiblepathogenic factor of melanocyte damage in vitiligo. J Invest Dermatol 109(3): 310-313.

Mannervik B, Awasthi YC, Board PG, Hayes JD, Di Ilio C, Ketterer B, ListowskyI, Morgenstern R, Muramatsu M & Pearson WR. (1992) Nomenclature for humanglutathione transferases. Biochem J 282 ( Pt 1)(Pt 1): 305-306.

Majumder PP, Nordlund JJ & Nath SK. (1993) Pattern of familial aggregation ofvitiligo. Arch Dermatol 129(8): 994-998.

Maidhof W & Hilas O. (2012) Lupus: an overview of the disease and managementoptions. P T 37(4): 240-249.

Lundstrom E, Hartshorne T, Li K, Lindblad S, Wick MC, Bengtsson C, AlfredssonL, Klareskog L & Padyukov L. (2011) Effects of GSTM1 in rheumatoid arthritis;results from the Swedish EIRA study. PLoS One 6(3): e17880.

Lu L, Wu W, Tu Y, Yang Z, He L & Guo M. (2014) Association of glutathione StransferaseM1/T1 polymorphisms with susceptibility to vitiligo. Gene 535(1): 12-16.

Liu XM, Zhou Q, Xu SZ, Wakamatsu K & Lei TC. (2011) Maintenance ofimmune hyporesponsiveness to melanosomal proteins by DHICA-mediatedantioxidation: Possible implications for autoimmune vitiligo. Free Radic Biol Med50(9): 1177-1185.

Liu L, Li C, Gao J, Li K, Gao L & Gao T. (2009) Genetic polymorphisms ofglutathione S-transferase and risk of vitiligo in the Chinese population. J InvestDermatol 129(11): 2646-2652.

Levy L, Fautrel B, Barnetche T & Schaeverbeke T. (2008) Incidence and risk offatal myocardial infarction and stroke events in rheumatoid arthritis patients. Asystematic review of the literature. Clin Exp Rheumatol 26(4): 673-679.

Lee DM & Weinblatt ME. (2001) Rheumatoid arthritis. Lancet 358(9285): 903-911.

Le Poole IC, van den Wijngaard RM, Westerhof W & Das PK. (1996) Presence ofT cells and macrophages in inflammatory vitiligo skin parallels melanocytedisappearance. Am J Pathol 148(4): 1219-1228.

Landi S. (2000) Mammalian class theta GST and differential susceptibility tocarcinogens: a review. Mutat Res 463(3): 247-283.

Laisney V, Nguyen Van C, Gross MS & Frezal J. (1984) Human genes forglutathione S-transferases. Hum Genet 68(3): 221-227.

Ladero JM, Martinez C, Garcia-Martin E, Fernandez-Arquero M, Lopez-Alonso G,de la Concha EG, Diaz-Rubio M & Agundez JA. (2005) Polymorphisms of theglutathione S-transferases mu-1 (GSTM1) and theta-1 (GSTT1) and the risk ofadvanced alcoholic liver disease. Scand J Gastroenterol 40(3): 348-353.

Kyriakis KP, Palamaras I, Tsele E, Michailides C & Terzoudi S. (2009) Casedetection rates of vitiligo by gender and age. Int J Dermatol 48(3): 328-329.

Kruger C & Schallreuter KU. (2012) A review of the worldwide prevalence ofvitiligo in children/adolescents and adults. Int J Dermatol 51(10): 1206-1212.

Kochi Y, Suzuki A, Yamada R & Yamamoto K. (2009) Genetics of rheumatoidarthritis: underlying evidence of ethnic differences. J Autoimmun 32(3-4): 158-162.

Klinman DM & Steinberg AD. (1995) Inquiry into murine and human lupus.Immunol Rev 144: 157-193.

Klareskog L, Stolt P, Lundberg K, Kallberg H, Bengtsson C, Grunewald J,Ronnelid J, Harris HE, Ulfgren AK, Rantapaa-Dahlqvist S, Eklund A, Padyukov L& Alfredsson L. (2006) A new model for an etiology of rheumatoid arthritis:smoking may trigger HLA-DR (shared epitope)-restricted immune reactions toautoantigens modified by citrullination. Arthritis Rheum 54(1): 38-46.

Kiyohara C, Washio M, Horiuchi T, Asami T, Ide S, Atsumi T, Kobashi G,Takahashi H, Tada Y & Kyushu Sapporo SLE (KYSS) Study Group. (2012) Riskmodification by CYP1A1 and GSTM1 polymorphisms in the association ofcigarette smoking and systemic lupus erythematosus in a Japanese population.Scand J Rheumatol 41(2): 103-109.

Kisselev P, Schunck WH, Roots I & Schwarz D. (2005) Association of CYP1A1polymorphisms with differential metabolic activation of 17beta-estradiol andestrone. Cancer Res 65(7): 2972-2978.

Keenan BT, Chibnik LB, Cui J, Ding B, Padyukov L, Kallberg H, Bengtsson C,Klareskog L, Alfredsson L & Karlson EW. (2010) Effect of interactions ofglutathione S-transferase T1, M1, and P1 and HMOX1 gene promoterpolymorphisms with heavy smoking on the risk of rheumatoid arthritis. ArthritisRheum 62(11): 3196-3210.

Kato T, Miyakawa H & Ishibashi M. (2004) Frequency and significance of antiglutathioneS-transferase autoantibody (anti-GST A1-1) in autoimmune hepatitis. JAutoimmun 22(3): 211-216.

Kato H, Inoue O, Kawasaki T, Fujiwara H, Watanabe T & Toshima H. (1992)Adult coronary artery disease probably due to childhood Kawasaki disease. Lancet340(8828): 1127-1129.

Karlson EW, Watts J, Signorovitch J, Bonetti M, Wright E, Cooper GS,McAlindon TE, Costenbader KH, Massarotti EM, Fitzgerald LM, Jajoo R, HusniME, Fossel AH, Pankey H, Ding WZ, Knorr R, Condon S & Fraser PA. (2007)Effect of glutathione S-transferase polymorphisms and proximity to hazardouswaste sites on time to systemic lupus erythematosus diagnosis: results from theRoxbury lupus project. Arthritis Rheum 56(1): 244-254.

Karlson EW, Chang SC, Cui J, Chibnik LB, Fraser PA, De Vivo I & CostenbaderKH. (2010) Gene-environment interaction between HLA-DRB1 shared epitope andheavy cigarette smoking in predicting incident rheumatoid arthritis. Ann RheumDis 69(1): 54-60.

Kariuki SN & Niewold TB. (2010) Genetic regulation of serum cytokines insystemic lupus erythematosus. Transl Res 155(3): 109-117.

Kaouass M, Deloyer P, Gouders I, Peulen O & Dandrifosse G. (1997) Role ofinterleukin-1 beta, interleukin-6, and TNF-alpha in intestinal maturation induced bydietary spermine in rats. Endocrine 6(2): 187-194.

Kang TY, El-Sohemy A, Comelis MC, Eny KM & Bae SC. (2005) Glutathione Stransferasegenotype and risk of systemic lupus erythematosus in Koreans. Lupus14(5): 381-384.

Kallberg H, Padyukov L, Plenge RM, Ronnelid J, Gregersen PK, van der HelmvanMil AH, Toes RE, Huizinga TW, Klareskog L, Alfredsson L &Epidemiological Investigation of Rheumatoid Arthritis study group. (2007) Genegeneand gene-environment interactions involving HLA-DRB1, PTPN22, andsmoking in two subsets of rheumatoid arthritis. Am J Hum Genet 80(5): 867-875.

Kagaya K, Miyakawa Y, Watanabe K & Fukazawa Y. (1992) Antigenic role ofstress-induced catalase of Salmonella typhimurium in cell-mediated immunity.Infect Immun 60(5): 1820-1825.

Juronen E, Tasa G, Uuskula M, Pooga M & Mikelsaar AV. (1996) Purification,characterization and tissue distribution of human class theta glutathione StransferaseT1-1. Biochem Mol Biol Int 39(1): 21-29.

Juang YT, Wang Y, Jiang G, Peng HB, Ergin S, Finnell M, Magilavy A, KyttarisVC & Tsokos GC. (2008) PP2A dephosphorylates Elf-1 and determines theexpression of CD3zeta and FcRgamma in human systemic lupus erythematosus Tcells. J Immunol 181(5): 3658-3664.

Josephy PD. (2010) Genetic variations in human glutathione transferase enzymes:significance for pharmacology and toxicology. Hum Genomics Proteomics 2010:876940.

Jordan K, Clarke AM, Symmons DP, Fleming D, Porcheret M, Kadam UT & CroftP. (2007) Measuring disease prevalence: a comparison of musculoskeletal diseaseusing four general practice consultation databases. Br J Gen Pract 57(534): 7-14.

Jones DB, Howden CW, Burget DW, Kerr GD & Hunt RH. (1987) Acidsuppression in duodenal ulcer: a meta-analysis to define optimal dosing withantisecretory drugs. Gut 28(9): 1120-1127.

Joenje H. (1989) Genetic toxicology of oxygen. Mutat Res 219(4): 193-208.

Ji JD & Lee WJ. (2013) Association between the polymorphisms of glutathione Stransferasegenes and rheumatoid arthritis: a meta-analysis. Gene 521(1): 155-159.

Jemth P, Stenberg G, Chaga G & Mannervik B. (1996) Heterologous expression,purification and characterization of rat class theta glutathione transferase T2-2.Biochem J 316 ( Pt 1)(Pt 1): 131-136.

Jakobsson PJ, Thoren S, Morgenstern R & Samuelsson B. (1999) Identification ofhuman prostaglandin E synthase: a microsomal, glutathione-dependent, inducibleenzyme, constituting a potential novel drug target. Proc Natl Acad Sci U S A96(13): 7220-7225.

Izmirly PM, Llanos C, Lee LA, Askanase A, Kim MY & Buyon JP. (2010)Cutaneous manifestations of neonatal lupus and risk of subsequent congenital heartblock. Arthritis Rheum 62(4): 1153-1157.

Hung RJ, Boffetta P, Brockmoller J, Butkiewicz D, Cascorbi I, Clapper ML, GarteS, Haugen A, Hirvonen A, Anttila S, Kalina I, Le Marchand L, London SJ, RannugA, Romkes M, Salagovic J, Schoket B, Gaspari L & Taioli E. (2003) CYP1A1 andGSTM1 genetic polymorphisms and lung cancer risk in Caucasian non-smokers: apooled analysis. Carcinogenesis 24(5): 875-882.

Huang GY, Ma XJ, Huang M, Chen SB, Huang MR, Gui YH, Ning SB, Zhang TH,Du ZD, Yanagawa H & Kawasaki T. (2006) Epidemiologic pictures of Kawasakidisease in Shanghai from 1998 through 2002. J Epidemiol 16(1): 9-14.

Huang CL, Nordlund JJ & Boissy R. (2002) Vitiligo: a manifestation of apoptosis?Am J Clin Dermatol 3(5): 301-308.

Hoshino T, Nakamura H, Okamoto M, Kato S, Araya S, Nomiyama K, Oizumi K,Young HA, Aizawa H & Yodoi J. (2003) Redox-active protein thioredoxinprevents proinflammatory cytokine- or bleomycin-induced lung injury. Am JRespir Crit Care Med 168(9): 1075-1083.

Horiuchi T, Washio M, Kiyohara C, Tsukamoto H, Tada Y, Asami T, Ide S,Kobashi G, Takahashi H & Kyushu Sapporo SLE Study Group. (2009)Combination of TNF-RII, CYP1A1 and GSTM1 polymorphisms and the risk ofJapanese SLE: findings from the KYSS study. Rheumatology (Oxford) 48(9):1045-1049.

Hitchon CA & El-Gabalawy HS. (2004) Oxidation in rheumatoid arthritis.Arthritis Res Ther 6(6): 265-278.

Hewagama A & Richardson B. (2009) The genetics and epigenetics of autoimmunediseases. J Autoimmun 33(1): 3-11.

Heliovaara M, Knekt P, Aho K, Aaran RK, Alfthan G & Aromaa A. (1994) Serumantioxidants and risk of rheumatoid arthritis. Ann Rheum Dis 53(1): 51-53.

Hazneci E, Karabulut AB, Ozturk C, Batcioglu K, Dogan G, Karaca S & EsrefogluM. (2005) A comparative study of superoxide dismutase, catalase, and glutathioneperoxidase activities and nitrate levels in vitiligo patients. Int J Dermatol 44(8):636-640.

Hayes JD, Flanagan JU & Jowsey IR. (2005) Glutathione transferases. Annu RevPharmacol Toxicol 45: 51-88.

Hayes JD & Strange RC. (2000) Glutathione S-transferase polymorphisms and theirbiological consequences. Pharmacology 61(3): 154-166.

Hayes JD & Pulford DJ. (1995) The glutathione S-transferase supergene family:regulation of GST and the contribution of the isoenzymes to cancerchemoprotection and drug resistance. Crit Rev Biochem Mol Biol 30(6): 445-600.

Hasegawa M. (2010) B lymphocytes: shedding new light on the pathogenesis ofsystemic sclerosis. J Dermatol 37(1): 3-10.

Handa S & Kaur I. (1999) Vitiligo: clinical findings in 1436 patients. J Dermatol26(10): 653-657.

Han JW, Zheng HF, Cui Y, Sun LD, Ye DQ, Hu Z, Xu JH, Cai ZM, Huang W,Zhao GP, Xie HF, Fang H, Lu QJ, Xu JH, Li XP, Pan YF, Deng DQ, Zeng FQ, YeZZ, Zhang XY, Wang QW, Hao F, Ma L, Zuo XB, Zhou FS, Du WH, Cheng YL,Yang JQ, Shen SK, Li J, Sheng YJ, Zuo XX, Zhu WF, Gao F, Zhang PL, Guo Q,Li B, Gao M, Xiao FL, Quan C, Zhang C, Zhang Z, Zhu KJ, Li Y, Hu DY, Lu WS,Huang JL, Liu SX, Li H, Ren YQ, Wang ZX, Yang CJ, Wang PG, Zhou WM, LvYM, Zhang AP, Zhang SQ, Lin D, Li Y, Low HQ, Shen M, Zhai ZF, Wang Y,Zhang FY, Yang S, Liu JJ & Zhang XJ. (2009) Genome-wide association study ina Chinese Han population identifies nine new susceptibility loci for systemic lupuserythematosus. Nat Genet 41(11): 1234-1237.

Halliwell B. (1999) Vitamin C: poison, prophylactic or panacea? Trends BiochemSci 24(7): 255-259.

Halliwell B & Grootveld M. (1987) The measurement of free radical reactions inhumans. Some thoughts for future experimentation. FEBS Lett 213(1): 9-14.

Hall AG, Autzen P, Cattan AR, Malcolm AJ, Cole M, Kernahan J & Reid MM.(1994) Expression of mu class glutathione S-transferase correlates with event-freesurvival in childhood acute lymphoblastic leukemia. Cancer Res 54(20): 5251-5254.

Habdous M, Siest G, Herbeth B, Vincent-Viry M & Visvikis S. (2004) GlutathioneS-transferases genetic polymorphisms and human diseases: overview ofepidemiological studies. Ann Biol Clin (Paris) 62(1): 15-24.

Ha HC, Sirisoma NS, Kuppusamy P, Zweier JL, Woster PM & Casero RA,Jr. (1998)The natural polyamine spermine functions directly as a free radical scavenger. ProcNatl Acad Sci U S A 95(19): 11140-11145.

Guy CA, Hoogendoorn B, Smith SK, Coleman S, O'Donovan MC & Buckland PR.(2004) Promoter polymorphisms in glutathione-S-transferase genes affecttranscription. Pharmacogenetics 14(1): 45-51.

Guthenberg C, Warholm M, Rane A & Mannervik B. (1986) Two distinct forms ofglutathione transferase from human foetal liver. Purification and comparison withisoenzymes isolated from adult liver and placenta. Biochem J 235(3): 741-745.

Guarneri F, Asmundo A, Sapienza D & Cannavo SP. (2011) Glutathione StransferaseM1/T1 gene polymorphisms and vitiligo in a Mediterranean population.Pigment Cell Melanoma Res 24(4): 731-733.

Gualtierotti R, Biggioggero M, Penatti AE & Meroni PL. (2010) Updating on thepathogenesis of systemic lupus erythematosus. Autoimmun Rev 10(1): 3-7.

Grimes PE, Morris R, Avaniss-Aghajani E, Soriano T, Meraz M & Metzger A.(2004) Topical tacrolimus therapy for vitiligo: therapeutic responses and skinmessenger RNA expression of proinflammatory cytokines. J Am Acad Dermatol51(1): 52-61.

Griffiths HR. (2008) Is the generation of neo-antigenic determinants by freeradicals central to the development of autoimmune rheumatoid disease?Autoimmun Rev 7(7): 544-549.

Gregersen PK, Silver J & Winchester RJ. (1987) The shared epitope hypothesis.An approach to understanding the molecular genetics of susceptibility torheumatoid arthritis. Arthritis Rheum 30(11): 1205-1213.

Gregersen PK, Amos CI, Lee AT, Lu Y, Remmers EF, Kastner DL, Seldin MF,Criswell LA, Plenge RM, Holers VM, Mikuls TR, Sokka T, Moreland LW, BridgesSL,Jr, Xie G, Begovich AB & Siminovitch KA. (2009) REL, encoding a memberof the NF-kappaB family of transcription factors, is a newly defined risk locus forrheumatoid arthritis. Nat Genet 41(7): 820-823.

Goth-Goldstein R, Stampfer MR, Erdmann CA & Russell M. (2000)Interindividual variation in CYP1A1 expression in breast tissue and the role ofgenetic polymorphism. Carcinogenesis 21(11): 2119-2122.

Glassman SJ. (2011) Vitiligo, reactive oxygen species and T-cells. Clin Sci (Lond)120(3): 99-120.

Girisha KM, Gilmour A, Mastana S, Singh VP, Sinha N, Tewari S, Ramesh V,Sankar VH & Agrawal S. (2004) T1 and M1 polymorphism in glutathione S-121 -transferase gene and coronary artery disease in North Indian population. Indian JMed Sci 58(12): 520-526.

Ghelani AM, Samanta A, Jones AC & Mastana SS. (2011) Association analysis ofTNFR2, VDR, A2M, GSTT1, GSTM1, and ACE genes with rheumatoid arthritis inSouth Asians and Caucasians of East Midlands in the United Kingdom. RheumatolInt 31(10): 1355-1361.

Garte S, Gaspari L, Alexandrie AK, Ambrosone C, Autrup H, Autrup JL,Baranova H, Bathum L, Benhamou S, Boffetta P, Bouchardy C, Breskvar K,Brockmoller J, Cascorbi I, Clapper ML, Coutelle C, Daly A, Dell'Omo M, DolzanV, Dresler CM, Fryer A, Haugen A, Hein DW, Hildesheim A, Hirvonen A, HsiehLL, Ingelman-Sundberg M, Kalina I, Kang D, Kihara M, Kiyohara C, Kremers P,Lazarus P, Le Marchand L, Lechner MC, van Lieshout EM, London S, Manni JJ,Maugard CM, Morita S, Nazar-Stewart V, Noda K, Oda Y, Parl FF, Pastorelli R,Persson I, Peters WH, Rannug A, Rebbeck T, Risch A, Roelandt L, Romkes M,Ryberg D, Salagovic J, Schoket B, Seidegard J, Shields PG, Sim E, Sinnet D,Strange RC, Stucker I, Sugimura H, To-Figueras J, Vineis P, Yu MC & Taioli E.(2001) Metabolic gene polymorphism frequencies in control populations. CancerEpidemiol Biomarkers Prev 10(12): 1239-1248.

Gao Y, Cao Y, Tan A, Liao C, Mo Z & Gao F. (2010) Glutathione S-transferase M1polymorphism and sporadic colorectal cancer risk: An updating meta-analysis andHuGE review of 36 case-control studies. Ann Epidemiol 20(2): 108-121.

Galan P, Preziosi P, Monget AL, Richard MJ, Arnaud J, Lesourd B, Girodon F,Alferez MJ, Bourgeois C, Keller H, Favier A & Hercberg S. (1997) Effects of traceelement and/or vitamin supplementation on vitamin and mineral status, free radicalmetabolism and immunological markers in elderly long term-hospitalized subjects.Geriatric Network MIN. VIT. AOX. Int J Vitam Nutr Res 67(6): 450-460.

Fraser PA, Ding WZ, Mohseni M, Treadwell EL, Dooley MA, St Clair EW,Gilkeson GS & Cooper GS. (2003) Glutathione S-transferase M null homozygosityand risk of systemic lupus erythematosus associated with sun exposure: a possiblegene-environment interaction for autoimmunity. J Rheumatol 30(2): 276-282.

Franco R, Panayiotidis MI & Cidlowski JA. (2007) Glutathione depletion isnecessary for apoptosis in lymphoid cells independent of reactive oxygen speciesformation. J Biol Chem 282(42): 30452-30465.

Firestein GS. (2003) Evolving concepts of rheumatoid arthritis. Nature 423(6937):356-361.

Fernando MM, Stevens CR, Walsh EC, De Jager PL, Goyette P, Plenge RM, VyseTJ & Rioux JD. (2008) Defining the role of the MHC in autoimmunity: a reviewand pooled analysis. PLoS Genet 4(4): e1000024.

Fatma A. Abd Rabou, Hesham A.Elserogy, Shereen F. Gheida and Amal A. ELAshmawy.(2011) Glutathione STransferase Gene Polymorphisms (GSTM1 and GSTT1)in Vitiligo Patients. Life Science Journal, 8(4):785-792.

Engel LS, Taioli E, Pfeiffer R, Garcia-Closas M, Marcus PM, Lan Q, Boffetta P,Vineis P, Autrup H, Bell DA, Branch RA, Brockmoller J, Daly AK, Heckbert SR,Kalina I, Kang D, Katoh T, Lafuente A, Lin HJ, Romkes M, Taylor JA & RothmanN. (2002) Pooled analysis and meta-analysis of glutathione S-transferase M1 andbladder cancer: a HuGE review. Am J Epidemiol 156(2): 95-109.

Egger M, Smith GD & Phillips AN. (1997) Meta-analysis: principles andprocedures. BMJ 315(7121): 1533-1537.

Edwards P, Clarke M, DiGuiseppi C, Pratap S, Roberts I & Wentz R. (2002)Identification of randomized controlled trials in systematic reviews: accuracy andreliability of screening records. Stat Med 21(11): 1635-1640.

Duncan H, Swan C, Green J, Jones P, Brannigan K, Alldersea J, Fryer AA &Strange RC. (1995) Susceptibility to ulcerative colitis and Crohn's disease:interactions between glutathione S-transferase GSTM1 and GSTT1 genotypes. ClinChim Acta 240(1): 53-61.

Doney AS, Lee S, Leese GP, Morris AD & Palmer CN. (2005) Increasedcardiovascular morbidity and mortality in type 2 diabetes is associated with theglutathione S transferase theta-null genotype: a Go-DARTS study. Circulation111(22): 2927-2934.

Deneke SM & Fanburg BL. (1989) Regulation of cellular glutathione. Am JPhysiol 257(4 Pt 1): L163-73.

Deighton CM, Walker DJ, Griffiths ID & Roberts DF. (1989) The contribution ofHLA to rheumatoid arthritis. Clin Genet 36(3): 178-182.

D'Cruz DP. (2006) Systemic lupus erythematosus. BMJ 332(7546): 890-894.

Crofts F, Taioli E, Trachman J, Cosma GN, Currie D, Toniolo P & Garte SJ. (1994)Functional significance of different human CYP1A1 genotypes. Carcinogenesis15(12): 2961-2963.

Criswell LA, Saag KG, Mikuls TR, Cerhan JR, Merlino LA, Lum RF, Pfeiffer KA,Woehl B & Seldin MF. (2006) Smoking interacts with genetic risk factors in thedevelopment of rheumatoid arthritis among older Caucasian women. Ann RheumDis 65(9): 1163-1167.

Criswell LA, Merlino LA, Cerhan JR, Mikuls TR, Mudano AS, Burma M, FolsomAR & Saag KG. (2002) Cigarette smoking and the risk of rheumatoid arthritisamong postmenopausal women: results from the Iowa Women's Health Study. AmJ Med 112(6): 465-471.

Crispin JC, Kyttaris VC, Juang YT & Tsokos GC. (2008) How signaling and genetranscription aberrations dictate the systemic lupus erythematosus T cell phenotype.Trends Immunol 29(3): 110-115.

Crispin JC, Kyttaris V, Juang YT & Tsokos GC. (2007) Systemic lupuserythematosus: new molecular targets. Ann Rheum Dis 66 Suppl 3: iii65-9.

Cotton SC, Sharp L, Little J & Brockton N. (2000) Glutathione S-transferasepolymorphisms and colorectal cancer: a HuGE review. Am J Epidemiol 151(1): 7-32.

Cote ML, Chen W, Smith DW, Benhamou S, Bouchardy C, Butkiewicz D, FongKM, Gene M, Hirvonen A, Kiyohara C, Larsen JE, Lin P, Raaschou-Nielsen O,Povey AC, Reszka E, Risch A, Schneider J, Schwartz AG, Sorensen M, To-Figueras J, Tokudome S, Pu Y, Yang P, Wenzlaff AS, Wikman H & Taioli E.(2009) Meta- and pooled analysis of GSTP1 polymorphism and lung cancer: aHuGE-GSEC review. Am J Epidemiol 169(7): 802-814.

Costenbader KH, Feskanich D, Mandl LA & Karlson EW. (2006) Smokingintensity, duration, and cessation, and the risk of rheumatoid arthritis in women.Am J Med 119(6): 503.e1-503.e9.

Comstock KE, Johnson KJ, Rifenbery D & Henner WD. (1993) Isolation andanalysis of the gene and cDNA for a human Mu class glutathione S-transferase,GSTM4. J Biol Chem 268(23): 16958-16965.

Coggan M, Whitbread L, Whittington A & Board P. (1998) Structure andorganization of the human theta-class glutathione S-transferase and D-dopachrometautomerase gene complex. Biochem J 334 ( Pt 3)(Pt 3): 617-623.

Coggan M, Flanagan JU, Parker MW, Vichai V, Pearson WR & Board PG. (2002)Identification and characterization of GSTT3, a third murine Theta classglutathione transferase. Biochem J 366(Pt 1): 323-332.

Clowse ME, Jamison M, Myers E & James AH. (2008) A national study of thecomplications of lupus in pregnancy. Am J Obstet Gynecol 199(2): 127.e1-127.e6.

Circu ML & Aw TY. (2010) Reactive oxygen species, cellular redox systems, andapoptosis. Free Radic Biol Med 48(6): 749-762.

Circu ML & Aw TY. (2008) Glutathione and apoptosis. Free Radic Res 42(8):689-706.

Chung J, Oh SY & Shin YK. (2009) Association of glutathione-S-transferasepolymorphisms with atopic dermatitis risk in preschool age children. Clin ChemLab Med 47(12): 1475-1481.

Cho SG, Lee YH, Park HS, Ryoo K, Kang KW, Park J, Eom SJ, Kim MJ, Chang TS,Choi SY, Shim J, Kim Y, Dong MS, Lee MJ, Kim SG, Ichijo H & Choi EJ. (2001)Glutathione S-transferase mu modulates the stress-activated signals by suppressingapoptosis signal-regulating kinase 1. J Biol Chem 276(16): 12749-12755.

Chenevix-Trench G, Young J, Coggan M & Board P. (1995) Glutathione StransferaseM1 and T1 polymorphisms: susceptibility to colon cancer and age ofonset. Carcinogenesis 16(7): 1655-1657.

Chen F, Lu Y, Demers LM, Rojanasakul Y, Shi X, Vallyathan V & Castranova V.(1998) Role of hydroxyl radical in silica-induced NF-kappa B activation inmacrophages. Ann Clin Lab Sci 28(1): 1-13.

Chen C, Zhou J, Xu H, Jiang Y & Zhu G. (1997) Effect of seleniumsupplementation on mice infected with LP-BM5 MuLV, a murine AIDS model.Biol Trace Elem Res 59(1-3): 187-193.

Chasseaud LF. (1979) The role of glutathione and glutathione S-transferases in themetabolism of chemical carcinogens and other electrophilic agents. Adv CancerRes 29: 175-274.

Cascorbi I, Brockmoller J & Roots I. (1996) A C4887A polymorphism in exon 7of human CYP1A1: population frequency, mutation linkages, and impact on lungcancer susceptibility. Cancer Res 56(21): 4965-4969.

Carlsten C, Sagoo GS, Frodsham AJ, Burke W & Higgins JP. (2008) Glutathione StransferaseM1 (GSTM1) polymorphisms and lung cancer: a literature-basedsystematic HuGE review and meta-analysis. Am J Epidemiol 167(7): 759-774.

Campbell E, Takahashi Y, Abramovitz M, Peretz M & Listowsky I. (1990) Adistinct human testis and brain mu-class glutathione S-transferase. Molecularcloning and characterization of a form present even in individuals lacking hepatictype mu isoenzymes. J Biol Chem 265(16): 9188-9193.

Calhoun WJ, Reed HE, Moest DR & Stevens CA. (1992) Enhanced superoxideproduction by alveolar macrophages and air-space cells, airway inflammation, andalveolar macrophage density changes after segmental antigen bronchoprovocationin allergic subjects. Am Rev Respir Dis 145(2 Pt 1): 317-325.

Cai Z, Zuo R & Liu Y. (2011) Characteristics of Kawasaki disease in olderchildren. Clin Pediatr (Phila) 50(10): 952-956.

Burns JC, Shike H, Gordon JB, Malhotra A, Schoenwetter M & Kawasaki T.(1996) Sequelae of Kawasaki disease in adolescents and young adults. J Am CollCardiol 28(1): 253-257.

Burns JC, Mason WH, Glode MP, Shulman ST, Melish ME, Meissner C, Bastian J,Beiser AS, Meyerson HM & Newburger JW. (1991) Clinical and epidemiologiccharacteristics of patients referred for evaluation of possible Kawasaki disease.United States Multicenter Kawasaki Disease Study Group. J Pediatr 118(5): 680-686.

Burns JC & Glode MP. (2004) Kawasaki syndrome. Lancet 364(9433): 533-544.

Bunnell E & Pacht ER. (1993) Oxidized glutathione is increased in the alveolarfluid of patients with the adult respiratory distress syndrome. Am Rev Respir Dis148(5): 1174-1178.

Buckley PG, Mantripragada KK, Diaz de Stahl T, Piotrowski A, Hansson CM,Kiss H, Vetrie D, Ernberg IT, Nordenskjold M, Bolund L, Sainio M, Rouleau GA,Niimura M, Wallace AJ, Evans DG, Grigelionis G, Menzel U & Dumanski JP.(2005) Identification of genetic aberrations on chromosome 22 outside the NF2locus in schwannomatosis and neurofibromatosis type 2. Hum Mutat 26(6): 540-549.

Brockmoller J, Cascorbi I, Kerb R & Roots I. (1996) Combined analysis ofinherited polymorphisms in arylamine N-acetyltransferase 2, glutathione StransferasesM1 and T1, microsomal epoxide hydrolase, and cytochrome P450enzymes as modulators of bladder cancer risk. Cancer Res 56(17): 3915-3925.

Brind AM, Hurlstone A, Edrisinghe D, Gilmore I, Fisher N, Pirmohamed M &Fryer AA. (2004) The role of polymorphisms of glutathione S-transferases GSTM1,M3, P1, T1 and A1 in susceptibility to alcoholic liver disease. Alcohol Alcohol39(6): 478-483.

Bowes J & Barton A. (2008) Recent advances in the genetics of RA susceptibility.Rheumatology (Oxford) 47(4): 399-402.

Borst L, Buchard A, Rosthoj S, Wesolowska A, Wehner PS, Wesenberg F, DalhoffK & Schmiegelow K. (2012) Gene dose effects of GSTM1, GSTT1 and GSTP1polymorphisms on outcome in childhood acute lymphoblastic leukemia. J PediatrHematol Oncol 34(1): 38-42.

Bohanec Grabar P, Logar D, Tomsic M, Rozman B & Dolzan V. (2009) Geneticpolymorphisms of glutathione S-transferases and disease activity of rheumatoidarthritis. Clin Exp Rheumatol 27(2): 229-236.

Board PG. (1981) Gene deletion and partial deficiency of the glutathione Stransferase(ligandin) system in man. FEBS Lett 135(1): 12-14.

Board PG. (1981) Biochemical genetics of glutathione-S-transferase in man. Am JHum Genet 33(1): 36-43.

Board PG & Menon D. (2013) Glutathione transferases, regulators of cellularmetabolism and physiology. Biochim Biophys Acta 1830(5): 3267-3288.

Block G, Shaikh N, Jensen CD, Volberg V & Holland N. (2011) Serum vitamin Cand other biomarkers differ by genotype of phase 2 enzyme genes GSTM1 andGSTT1. Am J Clin Nutr 94(3): 929-937.

Blake DR, Merry P, Unsworth J, Kidd BL, Outhwaite JM, Ballard R, Morris CJ,Gray L & Lunec J. (1989) Hypoxic-reperfusion injury in the inflamed human joint.Lancet 1(8633): 289-293.

Blackburn AC, Matthaei KI, Lim C, Taylor MC, Cappello JY, Hayes JD, AndersMW & Board PG. (2006) Deficiency of glutathione transferase zeta causesoxidative stress and activation of antioxidant response pathways. Mol Pharmacol69(2): 650-657.

Berman NG & Parker RA. (2002) Meta-analysis: neither quick nor easy. BMCMed Res Methodol 2: 10.

Berhane K, Widersten M, Engstrom A, Kozarich JW & Mannervik B. (1994)Detoxication of base propenals and other alpha, beta-unsaturated aldehyde productsof radical reactions and lipid peroxidation by human glutathione transferases. ProcNatl Acad Sci U S A 91(4): 1480-1484.

Becatti M, Prignano F, Fiorillo C, Pescitelli L, Nassi P, Lotti T & Taddei N. (2010)The involvement of Smac/DIABLO, p53, NF-kB, and MAPK pathways inapoptosis of keratinocytes from perilesional vitiligo skin: Protective effects ofcurcumin and capsaicin. Antioxid Redox Signal 13(9): 1309-1321.

Bax L, Yu LM, Ikeda N & Moons KG. (2007) A systematic comparison ofsoftware dedicated to meta-analysis of causal studies. BMC Med Res Methodol 7:40.

Bassiouny DA & Khorshied MM. (2013) Glutathione S-transferase M1 and T1genetic polymorphism in Egyptian patients with nonsegmental vitiligo. Clin ExpDermatol 38(2): 160-163.

Basham VM, Pharoah PD, Healey CS, Luben RN, Day NE, Easton DF, Ponder BA& Dunning AM. (2001) Polymorphisms in CYP1A1 and smoking: no associationwith breast cancer risk. Carcinogenesis 22(11): 1797-1800.

Barton A & Worthington J. (2009) Genetic susceptibility to rheumatoid arthritis:an emerging picture. Arthritis Rheum 61(10): 1441-1446.

Ballatori N, Krance SM, Notenboom S, Shi S, Tieu K & Hammond CL. (2009)Glutathione dysregulation and the etiology and progression of human diseases. BiolChem 390(3): 191-214.

Baker AL, Lu M, Minich LL, Atz AM, Klein GL, Korsin R, Lambert L, Li JS,Mason W, Radojewski E, Vetter VL, Newburger JW & Pediatric Heart NetworkInvestigators. (2009) Associated symptoms in the ten days before diagnosis ofKawasaki disease. J Pediatr 154(4): 592-595.e2.

Ashok BT & Ali R. (1999) The aging paradox: free radical theory of aging. ExpGerontol 34(3): 293-303.

Ashok BT & Ali R. (1998) Binding of human anti-DNA autoantibodies to reactiveoxygen species modified-DNA and probing oxidative DNA damage in cancer usingmonoclonal antibody. Int J Cancer 78(4): 404-409.

Ardesjo B, Hansson CM, Bruder CE, Rorsman F, Betterle C, Dumanski JP, KampeO & Ekwall O. (2008) Autoantibodies to glutathione S-transferase theta 1 inpatients with primary sclerosing cholangitis and other autoimmune diseases. JAutoimmun 30(4): 273-282.

Anantharaman D, Chaubal PM, Kannan S, Bhisey RA & Mahimkar MB. (2007)Susceptibility to oral cancer by genetic polymorphisms at CYP1A1, GSTM1 andGSTT1 loci among Indians: tobacco exposure as a risk modulator. Carcinogenesis28(7): 1455-1462.

Ames BN. (1989) Endogenous oxidative DNA damage, aging, and cancer. FreeRadic Res Commun 7(3-6): 121-128.

Allam M & Riad H. (2013) Concise review of recent studies in vitiligo. Qatar MedJ 2013(2): 1-19.

Alkhateeb A, Fain PR, Thody A, Bennett DC & Spritz RA. (2003) Epidemiologyof vitiligo and associated autoimmune diseases in Caucasian probands and theirfamilies. Pigment Cell Res 16(3): 208-214.

Alikhan A, Felsten LM, Daly M & Petronic-Rosic V. (2011) Vitiligo: acomprehensive overview Part I. Introduction, epidemiology, quality of life,diagnosis, differential diagnosis, associations, histopathology, etiology, and workup.J Am Acad Dermatol 65(3): 473-491.

Alexandrie AK, Rannug A, Juronen E, Tasa G & Warholm M. (2002) Detection andcharacterization of a novel functional polymorphism in the GSTT1 gene.Pharmacogenetics 12(8): 613-619.

Aguilera I, Wichmann I, Sousa JM, Bernardos A, Franco E, Garcia-Lozano JR &Nunez-Roldan A. (2001) Antibodies against glutathione S-transferase T1 (GSTT1)in patients with de novo immune hepatitis following liver transplantation. Clin ExpImmunol 126(3): 535-539.

Aguilera I, Sousa JM, Gavilan F, Bernardos A, Wichmann I & Nunez-Roldan A.(2004) Glutathione S-transferase T1 mismatch constitutes a risk factor for de novoimmune hepatitis after liver transplantation. Liver Transpl 10(9): 1166-1172.

Adler V, Yin Z, Fuchs SY, Benezra M, Rosario L, Tew KD, Pincus MR, Sardana M,Henderson CJ, Wolf CR, Davis RJ & Ronai Z. (1999) Regulation of JNK signalingby GSTp. EMBO J 18(5): 1321-1334.